25.06.2014 - Array Biopharma gradually grows along the support

The price of Array Biopharma continues to grow gradually within the descending channel and is now trying to gain a foothold above 4.25 and rebound from the sloping support line. In case of breaking through these levels, the company quotes may fall to 3.75 and 3.40. We expect the price growth along the inclined line of support to the upper boundary of the channel with the objectives at 4.50 and 4.75.

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.